Can a Wearable Really Replace the Pill? What Fertility & Ovulation-Tracking Tech Actually Proves

⚖️ Two Different Goals, Two Very Different Stakes

It’s worth establishing this distinction before anything else, because it changes how much accuracy actually matters. If you’re using a fertility tracker to try to conceive, a missed or inaccurate reading is a real inconvenience — but the consequence of a wrong prediction is usually just trying again next cycle. If you’re using the same category of device to avoid pregnancy, the exact same margin of error carries a fundamentally different, much higher-stakes consequence. Keep this distinction in mind throughout this article, because most of these devices are validated — to the extent they’re validated at all — for one of these two goals specifically, not both automatically.

🔬 What the Broader Research Actually Shows

The most current, comprehensive evidence in this category comes from a 2026 systematic review and Bayesian network meta-analysis published in npj Digital Medicine (Shi, Wang, Yang, Li, Chung, and Wang; DOI: 10.1038/s41746-025-02320-8), which pooled 27 studies (13 specifically evaluating ovulation tracking) to assess how accurately wearable digital technology detects the fertile window compared to conventional methods. The findings: a pooled diagnostic accuracy of 0.88 (95% CI: 0.86–0.90), sensitivity of 0.79 (95% CI: 0.70–0.87), and specificity of 0.80 — though that specificity figure came with a notably wide confidence interval (0.60–1.00), meaning real variability across the different devices and studies included.

⌚ Ava: The First FDA-Cleared Machine Learning Device for This Purpose

The Ava bracelet, worn overnight, tracks skin temperature, heart rate variability, respiratory rate, and perfusion. In 2021, it became the first machine-learning-based device to receive FDA 510(k) clearance specifically as an aid in ovulation prediction. It’s worth being precise about that regulatory language: Ava is cleared as a prediction aid, not as a contraceptive device, and not as a diagnostic tool — a meaningfully narrower claim than what Natural Cycles, discussed below, is cleared for.

💊 Natural Cycles: FDA-Cleared Birth Control — With a Real, Documented Controversy

This is the part of the category that deserves the most careful, honest treatment, because it involves real regulatory history that’s easy to oversimplify in either direction.

What actually happened. In August 2018, the FDA cleared Natural Cycles as the first app-based birth control method available in the United States, using a regulatory pathway designated for low-to-moderate-risk devices. The app has users track basal body temperature each morning (and can now incorporate Oura Ring temperature data), using an algorithm to identify fertile and non-fertile days.

The efficacy numbers genuinely differ depending on the source, and it’s worth seeing all of them rather than picking the most convenient one. The FDA’s own 2018 clearance announcement cited a typical-use failure rate of about 6.5% based on a large-scale clinical trial. An independent published review of the research literature by Dr. Chelsea Polis and colleagues, however, found a 9.8% typical-use unintended pregnancy rate based on the same broader body of published studies — a meaningfully higher figure than the FDA’s own cited number. Natural Cycles’ current marketing states a 7% typical-use and 1% perfect-use unintended pregnancy rate. These aren’t wildly contradictory numbers, but they aren’t identical either, and a genuinely independent reviewer (Polis) reported a higher failure rate than either the FDA’s announcement or the company’s own current marketing. It’s also worth noting a specific, sourced methodological critique: the National Center for Health Research, an independent watchdog organization, raised concerns that the pivotal study underlying the FDA’s clearance decision was conducted and funded by Natural Cycles itself, did not include a randomized control group, and relied on a self-selected sample of participants — all real, legitimate questions about study design, regardless of how the numbers ultimately shook out.

For context, here’s how those numbers compare to other contraceptive methods, using the FDA’s own cited figures at the time: the birth control pill has a typical-use failure rate around 9% (per CDC data), a hormonal IUD has a failure rate under 1%, condoms alone run around 18%, and traditional fertility-awareness (“rhythm”) methods run around 24%. Even taking the less favorable, independently reviewed 9.8% figure at face value, Natural Cycles performs comparably to the pill and meaningfully better than condoms alone or traditional rhythm-method tracking — genuinely useful context, even though it’s clearly less effective than a hormonal IUD.

💍 How the Oura Integration Actually Works

Oura’s temperature sensor measures skin temperature roughly 1,440 times per day directly from the finger while sleeping, which Oura states is precise to within 0.13°C and has been validated against research-grade tools at over 99% lab accuracy — a claim worth noting comes from the company itself rather than an independent third-party test, though it’s a specific, checkable figure rather than vague marketing language.

🌡️ Tempdrop: A Different Regulatory Status Worth Knowing About

Tempdrop, worn overnight to track basal body temperature, describes itself as “FDA-registered.” This is a meaningfully different, and lower, regulatory bar than FDA clearance — registration is essentially a listing requirement for device manufacturers, not a review of clinical evidence the way 510(k) clearance is. It’s a real regulatory status, but not the same claim as what Ava or Natural Cycles hold.

🔎 Other Devices Worth Knowing About

OvulaRing takes a different physical approach entirely: a vaginal biosensor measuring core body temperature directly, rather than skin temperature via a wrist or finger sensor — a design that, per commentary from the American Society for Reproductive Medicine (ASRM), reflects genuine ongoing innovation in how these signals can be measured. ASRM’s own overview of this category is a useful, professionally authoritative synthesis point: it describes wearable health devices as showing real promise for detecting fertility cycle stages, while being precise about which specific devices hold which specific regulatory status — echoing the same distinctions made throughout this article rather than treating the category as monolithic.

🎯 Why the Two-Goal Framing Matters More Than Any Single Accuracy Number

Bringing this back to the distinction from the opening: the broader 2026 meta-analysis’s pooled 0.79 sensitivity and specificity with a wide confidence interval (0.60–1.00) describes ovulation-detection performance generally, across many devices — not a guarantee for any single product, and critically, not a contraceptive-effectiveness statistic. If you’re trying to conceive, a device performing within that general accuracy range is a genuinely useful tool for narrowing down your most fertile days, with the understanding that some uncertainty remains, and the practical cost of an occasional miss is low. If you’re trying to avoid pregnancy, the relevant question isn’t “how accurate are fertility wearables generally” — it’s specifically “does this exact product hold a contraceptive-specific FDA clearance,” which, as of this writing, applies to Natural Cycles and not to Ava, Tempdrop, or a standalone Oura Ring. Using a device cleared only as a general “ovulation prediction aid” as your sole method of contraception is a meaningfully different, less evidence-supported choice than using the one product specifically cleared and studied for that exact purpose.

🚀 Why New Devices Keep Launching in This Category

It’s worth understanding the broader context driving how many new entrants keep appearing in this space, since it shapes how skeptically to read a brand-new product’s launch claims. Fertility and reproductive health technology (often called “femtech”) has become one of the fastest-growing corners of digital health investment, driven by a combination of rising interest in non-hormonal contraceptive options, growing use of fertility tracking among people actively trying to conceive, and broader consumer demand for personalized, data-driven health tools generally. That growth is genuine and reflects real, legitimate consumer need — the gap in dedicated reproductive health technology, relative to other health categories, was real and is being filled. But it also means new products launch frequently with limited independent track records, and — as shown throughout this article — the specific FDA status, study design, and evidence quality behind any single new entrant can vary enormously even within what looks like a single, homogeneous product category. A device launching today with confident marketing language deserves the same specific, source-by-source scrutiny applied to Ava, Natural Cycles, and Tempdrop above — the same “who funded the pivotal study” question worth asking that we raised about company-funded research in AI physical therapy platforms — rather than assumed credibility just because it fits a now-familiar, well-established product category.

📊 Quick Comparison

✅ Questions to Ask About Any Fertility or Ovulation Wearable

• Is this device cleared (or registered) by the FDA, and for exactly which specific claim — ovulation prediction as a conception aid, or contraception specifically? These are not interchangeable regulatory claims, as shown above.
• If you’re relying on this for contraception, is it Natural Cycles specifically, or a different device not studied or cleared for that exact purpose?
• Is a cited accuracy or efficacy figure independently published, or sourced from the company’s own marketing? As shown with Tempdrop and with Natural Cycles’ own current marketing numbers, these can differ from independently reviewed figures.
• Does the device use a single signal (like temperature alone) or multiple physiological parameters together? The 2026 meta-analysis found multi-parameter devices performed better than single-signal tracking.
• Are you using this to plan conception or to avoid pregnancy? The same device and the same accuracy numbers carry very different real-world stakes depending on the answer.

🙋 Who This Is Actually Right For

If you’re trying to conceive, the broader evidence base — including the 2026 meta-analysis’s pooled 0.88 accuracy figure — supports fertility wearables as a genuinely useful tool for narrowing your fertile window, particularly ring-type, multi-parameter devices, with the understanding that no device offers certainty and the consequence of an occasional miss is simply trying again.

If you’re specifically seeking a non-hormonal contraceptive method, Natural Cycles is the one product in this category with an actual FDA contraceptive clearance and published efficacy data to evaluate — though it’s worth weighing the real range of reported failure rates (6.5% to 9.8% typical-use, depending on the source) against other available methods, and discussing the decision with a healthcare provider given the documented history of unintended pregnancies that accompanied its early rollout.

If you have irregular cycles, a diagnosed reproductive health condition, or are undergoing fertility treatment, these consumer devices can be a useful data-gathering supplement, but shouldn’t replace the more direct clinical monitoring (like ultrasound-based ovulation tracking, which multiple sources in this space note remains the actual gold standard) that a fertility specialist would use for anything beyond general cycle awareness.

❓ Frequently Asked Questions

Is there really a wearable that’s FDA-approved as birth control?

Yes, with precision: Natural Cycles is an FDA-cleared app (not a wearable itself) that can incorporate temperature data from the Oura Ring, and it’s the only product in this category with an actual contraceptive-specific FDA clearance, granted in 2018.

How accurate is Natural Cycles as birth control?

Reported figures vary by source: the FDA’s clearance announcement cited a 6.5% typical-use failure rate, an independent published review found 9.8%, and the company’s current marketing states 7%. All of these are in a broadly similar range to the birth control pill, though less effective than a hormonal IUD.

Can I use my Oura Ring alone as birth control?

No. The Oura Ring itself is not FDA-cleared for fertility tracking or contraception. It’s the Natural Cycles app, interpreting Oura’s temperature data, that holds the actual contraceptive clearance — the ring is a data source, not an independently cleared contraceptive device on its own.

What’s the most accurate type of fertility-tracking wearable?

A 2026 meta-analysis of 27 studies found ring-type devices using multiple physiological parameters together (rather than a single signal like temperature alone), combined with random forest-based algorithms, performed best among the devices studied, with detection most reliable in the three days surrounding ovulation.

📚 Sources & References

• Shi, Y., Wang, C.C., Yang, Y., Li, Q., Chung, P.W., Wang, Y., “The diagnostic accuracy of wearable digital technology in detecting fertility window and menstrual cycles: a systematic review and Bayesian network meta-analysis,” npj Digital Medicine, 2026, DOI: 10.1038/s41746-025-02320-8
• American Society for Reproductive Medicine (ASRM), “Wearable Health Monitors and Fertility: Where Are We Now?”
• Reproductive Times, “Wired for Wellness: Is Wearable Tech the Future in Fertility Monitoring and General Reproductive Care?” (Ava FDA clearance history)
• STAT News, “FDA clears Natural Cycles, controversial app for contraception”
• NPR, “Annovera And Natural Cycles App Birth Control Options Approved By FDA” (Polis et al. 9.8% independent review figure)
• National Center for Health Research, “It’s Getting Easier to Get FDA Clearance — Just Ask Natural Cycles” and “Birth Control Apps Show the Contradictions in FDA Device Oversight”
• Fortune, “The FDA Approved a Digital Birth Control App This Month. It’s Raised Some Controversy”
• Pharmacy Times, “FDA Permits Marketing of First Direct-to-Consumer App for Contraceptive Use”
• Natural Cycles, “The Science Behind the Birth Control App” (current company-stated efficacy figures)
• Oura, “Oura Integrates With FDA-Cleared Birth Control App, Natural Cycles”
• Tempdrop, “5 Best Fertility and Ovulation Trackers for a 2026 Baby” (presented with source-bias caveat)
• The Bump, “Which to Choose? Ava vs. Tempdrop vs. Femometer”

Verification notes: The Natural Cycles FDA clearance, the Swedish hospital controversy (37 reported unintended pregnancies) and subsequent regulatory investigation, and the differing efficacy figures across the FDA’s announcement, the independent Polis et al. review, and the company’s own current marketing were all independently cross-checked across multiple contemporaneous and current sources (STAT News, NPR, Fortune, Pharmacy Times, National Center for Health Research, and Natural Cycles’ own site), rather than relying on a single source for this sensitive regulatory history. Tempdrop’s specific accuracy claims are explicitly labeled as company-sourced, since this article could not locate independent, third-party verification of those exact figures. The 2026 npj Digital Medicine meta-analysis was verified directly via its PMC listing, with figures quoted from the published abstract.

💡 The Bottom Line

The honest picture here has two real, true halves that shouldn’t be flattened into one simple verdict. The broader science of wearable ovulation detection is genuinely solid and improving — a real, current, large-scale meta-analysis backs that up. And one specific product, Natural Cycles, has cleared a real regulatory bar few realize exists: FDA authorization as an actual method of birth control. But “FDA-cleared” doesn’t mean “as effective as a hormonal IUD,” and it doesn’t mean every fertility wearable on the market carries the same claim or the same evidence behind it. A device that’s a legitimately useful aid for planning a pregnancy is not automatically an appropriate or equally evidenced choice for preventing one — and knowing exactly which specific claim a specific product’s clearance actually covers is the difference between an informed choice and an assumption that could carry real consequences.